SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-032744
Filing Date
2022-05-31
Accepted
2022-05-31 08:36:31
Documents
1
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4012
  Complete submission text file 0001209191-22-032744.txt   5396
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Issuer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LONGBOARD PHARMACEUTICALS, INC. 4275 EXECUTIVE DRIVE, SUITE 950 LA JOLLA CA 92037
Business Address
Tiller Jane (Reporting) CIK: 0001892867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40192 | Film No.: 22980684